About the ANCA-Associated Vasculitis Working Group
The methods for creating a composite outcome are different than for individual domain-directed outcomes and this Workshop will help attendees understand the steps required for this process through a project that is funded by ACR and EULAR to create response criteria for ANCA-associated vasculitis for use in clinical trials. Attendees are encouraged before the Workshop to view the short but highly informative videos developed to inform everyone on the disease under study and the methods employed for this project.
![Haner_Direskeneli Haner_Direskeneli](https://omeract.org/wp-content/uploads/bb-plugin/cache/Haner_Direskeneli-circle-1baf777c3f013df70f2677db34ffe00d-.jpg)
Haner Direskeneli
Co-Chair
![sarah mackie sarah mackie](https://omeract.org/wp-content/uploads/bb-plugin/cache/sarah-mackie-circle-299d47065926181002cf007bd67238fc-.png)
Sarah Mackie
Co-Chair
![Peter Merkel Peter Merkel](https://omeract.org/wp-content/uploads/bb-plugin/cache/Merkel.-circle-94aa78e606d4ed1ba1a2481972e32b64-.jpg)
Peter Merkel
Co-Chair
![gunnar gunnar](https://omeract.org/wp-content/uploads/bb-plugin/cache/gunnar-circle-de311c55f0746fee9ded67a6fcda783f-.jpg)
Gunnar Tómasson
Co-Chair
![kaitlin quinn kaitlin quinn](https://omeract.org/wp-content/uploads/bb-plugin/cache/kaitlin-quinn-circle-44b838edcab42259bc9e15619334c015-.jpg)
Kaitlin Quinn
Fellow
![Screen Shot 2021-02-17 at 11.40.13 AM Screen Shot 2021-02-17 at 11.40.13 AM](https://omeract.org/wp-content/uploads/bb-plugin/cache/Screen-Shot-2021-02-17-at-11.40.13-AM-circle-df923c21f06c77667a4f7a56c9497d81-.png)
Sara Monti
Fellow
![georgia lanier georgia lanier](https://omeract.org/wp-content/uploads/bb-plugin/cache/georgia-lanier-circle-b8768e780eca3c281ec6477256052a1e-.jpg)
Georgia Lanier
Patient Research Partner
Introduction to Antineutrophil cytoplasmic antibody ANCA-Associated Vasculitis
Introduction To Methodology To Develop A Composite Outcome Measure For ANCA-Associated Vasculitis
OMERACT Endorsed Core Domain Set for Clinical Trials in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
![Screenshot 2024-01-30 at 12.23.58 PM Screenshot 2024-01-30 at 12.23.58 PM](https://omeract.org/wp-content/uploads/2024/01/Screenshot-2024-01-30-at-12.23.58%E2%80%AFPM.png)
Working Group Publications
Developing a composite outcome tool to measure response to treatment in ANCA-associated vasculitis: A mixed methods study from OMERACT 2020
OMERACT Endorsement of Patient-reported Outcome Instruments in Antineutrophil Cytoplasmic Antibody–associated Vasculitis
Exploration, development, and validation of patient-reported outcomes in ANCA-associated vasculitis utilizing the OMERACT process
The OMERACT Core Set of Outcome Measures for Use in Clinical Trials of ANCA-associated Vasculitis
Working Group Members:
Alexa Meara
Beverley Shea
Carol Langford
Cristina Ponte
Georgia Lanier
Gulen Hatemi
Gunnar Tomasson
Haner Direskeneli
Kaitlin Quinn
Nataliya Milman
Peter Merkel
Peter Tugwell
Sara Monti
Sarah Mackie
Tanaz Kermani
Yesim Ozguler
Peter Grayson